Literature DB >> 26518109

Comparison of Holmium Laser Prostate Enucleation Outcomes in Patients with or without Preoperative Urinary Retention.

Niels V Johnsen1, Trisha J Kammann1, Tracy Marien1, Ryan B Pickens2, Nicole L Miller3.   

Abstract

PURPOSE: We determine whether outcomes of holmium laser enucleation of the prostate are similar in patients with and those without preoperative urinary retention.
MATERIALS AND METHODS: From May 2008 to July 2014, 231 patients underwent holmium laser prostate enucleation for symptomatic benign prostatic hyperplasia. Retrospective analysis was performed to evaluate for differences in postoperative outcomes for patients with and those without preoperative urinary retention.
RESULTS: Overall 95 patients (41%) had urinary retention before holmium laser prostate enucleation while 136 (59%) did not. Mean followup for all patients was 15.3 months. Patients with retention tended to be older, have larger prostates, and have higher scores on the AUA SS and bother questionnaires (all p <0.05). Postoperatively there was no difference in rates of complications, including urinary retention. Both groups showed significant improvement in AUA SS and bother score after the procedure at all postoperative points. Median post-void residual was less than 60 ml and median maximum flow rate on uninstrumented uroflow was greater than 18 ml per second at all postoperative points for all patients regardless of preoperative retention status. No patients required long-term catheterization and rates of postoperative complications did not differ significantly during the followup period.
CONCLUSIONS: This study represents the first direct comparison to our knowledge of holmium laser prostate enucleation outcomes in patients with or without urinary retention. There was no increased risk of postoperative urinary retention in patients with preoperative retention, and both groups demonstrated significant postoperative improvement in subjective and objective voiding measures.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  lasers; prostate; prostatic hyperplasia; solid-state; transurethral resection of prostate

Mesh:

Year:  2015        PMID: 26518109     DOI: 10.1016/j.juro.2015.10.116

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Metabolic syndrome is predictive of lower urinary tract symptom improvement after holmium laser enucleation of the prostate for benign prostatic obstruction.

Authors:  Taekmin Kwon; Sejun Park; Sungchan Park; Kyung Hyun Moon
Journal:  Int Urol Nephrol       Date:  2017-03-30       Impact factor: 2.370

2.  HoLEP for acute and non-neurogenic chronic urinary retention: how effective is it?

Authors:  Tevita Aho; William Finch; Philippa Jefferson; Lokesh Suraparaju; Fanourios Georgiades
Journal:  World J Urol       Date:  2021-03-24       Impact factor: 4.226

Review 3.  Holmium laser enucleation of the prostate: patient selection and perspectives.

Authors:  Tracy Marien; Mustafa Kadihasanoglu; Nicole L Miller
Journal:  Res Rep Urol       Date:  2016-10-21

4.  Comparison of 120 W 2-μm laser resection of the prostate outcomes in patients with or without preoperative urinary retention.

Authors:  Xiaolong Liu; Yongchang Wang; Jie Gao; Yuxi Shan
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2016-11-02       Impact factor: 1.195

5.  Our clinic's first experience with HoLEP.

Authors:  Serkan Dogan; Kenan Yigit Yildiz
Journal:  North Clin Istanb       Date:  2019-10-25

6.  Efficacy, safety, and perioperative outcomes of holmium laser enucleation of the prostate-a comparison of patients with lower urinary tract symptoms and urinary retention.

Authors:  Pawel Trotsenko; Christian Wetterauer; Philipp Grimsehl; Tilmann Möltgen; Susan Meierhans; Lukas Manka; Helge Seifert; Stephen Wyler; Maciej Kwiatkowski
Journal:  Lasers Med Sci       Date:  2020-10-30       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.